Increased serum levels of glutamate in adult patients with autism

BackgroundPrecise mechanisms underlying the pathophysiology of autism are currently unknown. Given the major role of glutamate in brain development, we have hypothesized that glutamatergic neurotransmission plays a role in the pathophysiology of autism. In this study, we studied whether amino acids (glutamate, glutamine, glycine, d-serine, and l-serine) related to glutamatergic neurotransmission are altered in serum of adult patients with autism.MethodsWe measured serum levels of amino acids in 18 male adult patients with autism and age-matched 19 male healthy subjects using high-performance liquid chromatography.ResultsSerum levels (mean = 89.2 μM, S.D. = 21.5) of glutamate in the patients with autism were significantly (t = − 4.48, df = 35, p < 0.001) higher than those (mean = 61.1 μM, S.D. = 16.5) of normal controls. In contrast, serum levels of other amino acids (glutamine, glycine, d-serine, l-serine) in the patients with autism did not differ from those of normal controls. There was a positive correlation (r = 0.523, p = 0.026) between serum glutamate levels and Autism Diagnostic Interview–Revised (ADI-R) social scores in patients.ConclusionsThe present study suggests that an abnormality in glutamatergic neurotransmission may play a role in the pathophysiology of autism.